Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project)

American Journal of Cardiology

Volumn 95, Issue 2, 2005, Pages 254-257

  Canner, Paul L ^a   Furberg, Curt D ^b   Terrin, Michael L ^a   McGovern, Mark E ^c  

^a MARYLAND MEDICAL RESEARCH INSTITUTE   (United States)

^b WAKE FOREST UNIVERSITY   (United States)

^c Kos Division of Medical Affairs   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; NICOTINIC ACID; PLACEBO;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALING; HEART INFARCTION; HUMAN; MALE; METHODOLOGY; MORTALITY; OUTCOMES RESEARCH; PATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION;

ANTILIPEMIC AGENTS; BLOOD GLUCOSE; FLORIDA; FOLLOW-UP STUDIES; HUMANS; MALE; MARYLAND; MYOCARDIAL INFARCTION; NIACIN; NORTH CAROLINA; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS;

EID: 11844304073     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.09.013     Document Type: Article

References (11)

1. The Coronary Drug Project Research Group The Coronary Drug Project Design, methods, and baseline results. Circulation 47 suppl I 1973 I-1 I-50
2. The Coronary Drug Project Research Group Clofibrate and niacin in coronary heart disease JAMA 231 1975 360 381
3. P.L. Canner, K.G. Berge, N.K. Wenger, J. Stamler, L. Friedman, R.J. Prineas, W. Friedewald Coronary Drug Project Research Group Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin J Am Coll Cardiol 8 1986 1245 1255
4. M.E. McGovern Use of nicotinic acid in patients with elevated fasting glucose, diabetes, or metabolic syndrome Br J Diabetes Vasc Dis 4 2004 78 85
5. A. Garg, S.M. Grundy Nicotinic acid as therapy for dyslipidemia in non-insulin-dependent diabetes mellitus JAMA 264 1990 723 726
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
7. D.R. Cox Regression models and life-tables J R Stat Soc B 34 1972 187 202
8. The Coronary Drug Project Research Group Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project N Engl J Med 303 1980 1038 1041
9. The Coronary Drug Project Research Group The prognostic importance of plasma glucose levels and of the use of oral hypoglycemic drugs after myocardial infarction in men Diabetes 26 1977 453 465
10. K.G. Berge, G.D. Molnar Effects of nicotinic acid on clinical aspects of carbohydrate metabolism R. Altschul Niacin in Vascular Disorders and Hyperlipidemia 1964 Charles C Thomas Springfield, IL 136 155
11. M. Miller Niacin as a component of combination therapy for dyslipidemia Mayo Clin Proc 78 2003 735 742